Versant Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.5K | Buy |
2,014
+1,851
| +1,136% | +$60.2K | 0.01% | 846 |
|
|
2025
Q1 | $6.16K | Buy |
163
+71
| +77% | +$2.68K | ﹤0.01% | 1948 |
|
|
2024
Q4 | $7.53K | Buy |
92
+74
| +411% | +$6.06K | ﹤0.01% | 1546 |
|
|
2024
Q3 | $2.06K | Buy |
+18
| New | +$2.06K | ﹤0.01% | 1555 |
|
|
2023
Q3 | – | Sell |
-9
| Closed | -$449 | – | 2022 |
|
|
2023
Q2 | $449 | Buy |
+9
| New | +$449 | ﹤0.01% | 1860 |
|